Olasińska-Wiśniewska Anna, Misterski Marcin, Grygier Marek, Konstanty-Kalandyk Janusz, Urbanowicz Tomasz, Lesiak Maciej, Jemielity Marek, Dąbrowski Maciej
Department of Cardiac Surgery and Transplantology, Poznan University of Medical Sciences, 61-848 Poznan, Poland.
I Department of Cardiology, Poznan University of Medical Sciences, 61-848 Poznan, Poland.
J Clin Med. 2025 Jan 23;14(3):735. doi: 10.3390/jcm14030735.
Transcatheter aortic valve implantation (TAVI) has become an optimal alternative in selected groups of patients and evolved from procedures in non-option patients to lower-risk-profile patients. One of its main indications is previous cardiac surgery, since redo-intervention is burdened with a higher risk of complications. However, TAVI after mitral valve surgery may raise concerns due to potential interference with the mitral prosthesis or ring during or after the procedure. The present paper reviews the current knowledge, including possible complications and procedural aspects.
经导管主动脉瓣植入术(TAVI)已成为特定患者群体的最佳选择,并从非可选患者的手术发展到风险较低的患者。其主要适应症之一是既往心脏手术,因为再次干预的并发症风险较高。然而,二尖瓣手术后的TAVI可能会引发担忧,因为在手术期间或术后可能会干扰二尖瓣假体或瓣环。本文综述了当前的知识,包括可能的并发症和手术相关方面。